Skip to main content

Wingrove Theresa's Form 4 filing

ImmunoGen, Inc.IMGN · filed Feb 6, 2024

Accession no.
0001415889-24-002872
Filed
Feb 6, 2024
Trade date
Feb 2-5, 2024
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market sales total $352.4K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Wingrove TheresaCIK 0001510720Officer (SVP OF REGULATORY AFFAIRS)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 2, 2024Common StockMOption exerciseAcquired+29,640$0.00$033,066Direct
Feb 5, 2024Common StockSSaleDisposed−12,027$29.30F2−$352,391.121,039Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 2, 2024Common StockMOption exerciseDisposed−21,840$0.00F3$032,760Direct
Feb 2, 2024Common StockMOption exerciseDisposed−7,800$0.00F3$015,600Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.295 to $29.315, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.

Referenced by the price of 1 transaction in Table I.

F3

Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.

Referenced by the price of 2 transactions in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)